Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
16
×
national blog main
biotech
clinical trials
san francisco blog main
boston blog main
fda
innovation
national
national top stories
raleigh-durham blog main
san francisco top stories
texas blog main
texas top stories
deals
drugs
europe blog main
new york blog main
raleigh-durham top stories
startups
venture capital
brexit
cancer
entrepreneur
europe
falsified medicines
labeling
life science
medical device
medical devices
mhra
new york top stories
regulations
san antonio
san diego blog main
san diego top stories
texas
uk
accelerator
akouos
What
plans
16
×
medicines
sciences
announced
company
end
life
new
san
antonio
brexit
cash
charting
choppy
course
drug
dynamic
fda
health
ipo
medical
period
post
regulation
regulatory
reveals
science
transition
uk
based
cancer
center
deal
developing
firm
investments
medicine
technologies
texas
venture
Language
unset
Current search:
plans
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
UT Health San Antonio Plans New Accelerator for Faculty Research
@xconomy.com
5 years ago
GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@venturebeat.com
6 years ago
Menlo Ventures banks on tech-driven life sciences, adds Greg Yap as new partner